Hong Kong· Hong KongHong Kong biotechnology stocks under pressure
Biotechnology stocks listed in Hong Kong are experiencing a downturn, with the Hang Seng Biotech Index falling by over 3%.
Background
Hong Kong operates under a 'One Country, Two Systems' framework, granting it a high degree of autonomy except in defense and foreign affairs. This unique status has fostered a dynamic financial market, but also led to ongoing political tensions regarding its relationship with mainland China. These tensions often influence various sectors, including its economy and regulatory environment.
Quorum · collective opinions
Hong Kong biotechnology stocks under pressure
First report 22h agoLast update 22h agoThe biotech sector in Hong Kong is facing significant pressure, leading to a notable drop in its main index.
iWitness comments
No comments yet — be the first to weigh in.